DCM
DRTX

Discovery Capital Management’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Discovery Capital Management’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-939,182
Closed -$12.6M – 172
2014
Q1 		$12.6M Sell
939,182
-249,389
-21% -$3.27M 0.09% 103
2013
Q4 		$15.2M Hold
1,188,571
– – 0.11% 97
2013
Q3 		$10.7M Hold
1,188,571
– – 0.09% 96
2013
Q2 		$8.56M Buy
+1,188,571
New +$8.73M 0.09% 85

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Discovery Capital Management's DRTX Position: Q2 2014 in Review

Discovery Capital Management sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q2 2014, closing a stake of 939,182 shares — an estimated $12.6M sold.

Discovery Capital Management first reported a position in DRTX in Q2 2013 and held it in 4 quarters. The position peaked at $15.2M in Q4 2013. 74 funds tracked by Wall St. Rank hold DRTX as of Q2 2014.

  • Discovery Capital Management reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Discovery Capital Management sold 939,182 DURATA THERAPEUTICS INC COM STK (DE) shares in Q2 2014, an estimated $12.6M.
  • Discovery Capital Management first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Discovery Capital Management's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $15.2M in Q4 2013.
  • 74 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q2 2014.

Based on Discovery Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.